Educational Notice
Peptidings provides information for educational and research purposes only. The peptides discussed on this page are subjects of ongoing scientific research. None of the information presented here constitutes medical advice or a recommendation for use. Consult a qualified healthcare provider before making any decisions about peptide use.
Browse by Condition
Joint Pain & Bone Health
Joint pain and bone health research involves two largely separate compound categories that are often conflated in self-experimentation communities. PTH-related peptides—teriparatide, abaloparatide, and palopegteriparatide—are FDA-approved drugs with extensive clinical records specifically for osteoporosis, a defined bone-density condition. BPC-157 and TB-500 are discussed for joint and soft tissue pain in community contexts but operate through entirely different mechanisms and have far weaker evidence bases for bone or joint applications specifically.
Approved Drug
Clinical Trials
Pilot / Human Data
Preclinical Only
It’s Complicated
Compounds with Research Relevant to Joint Pain and Bone Health
Each compound links to its full pillar article. The most useful sections for evaluating a specific application are the Claims vs. Evidence table and the Safety, Risks, and Limitations section. Evidence tiers reflect the strongest available data for a compound overall—not necessarily for this specific application.
WADA
BPC-157: What the Research Says about This Pentadecapeptide
Gastric pentadecapeptide studied for tissue repair, tendon healing, and gut protection. Pilot human data only; WADA prohibited.
Read the research →
WADA
TB-500: What the Research Says about Thymosin Beta-4’s Synthetic Fragment
Synthetic Thymosin Beta-4 fragment studied for tissue repair and cell migration. Preclinical evidence only; WADA prohibited.
Read the research →
WADA
Thymosin Beta-4: What the Research Shows
Endogenous 43-amino acid actin-sequestering peptide studied for wound healing, cardiac repair (RGN-352 Phase II), and corneal regeneration (RGN-259). TB-500 is its synthetic fragment — distinct compounds.
Read the research →
Guides Relevant to This Condition
How to Reconstitute Lyophilized Peptides
Bacteriostatic water, reconstitution ratios, vial handling
FDA Regulatory Explainer
Category 1, 2, and 3 compounds—what the classifications mean for research use
Peptide Injection Technique Guide
Subcutaneous and intramuscular injection, site rotation, safety
Research Cluster
These compounds are covered in depth in the Bone and Joint Health Peptides cluster hub.
Disclaimer: This page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. The compounds discussed have not been evaluated by the FDA for all applications described. Consult a qualified healthcare provider before making any decisions about your health.